Tissue engineering and its implications in dentistry

Indian Journal of Dental Research

Volumn 20, Issue 2, 2009, Pages 222-226

  Tyagi, Parimala ^a   Dhindsa, Manpreet ^a  

^a People s Dental Academy   (India)

Author keywords

Cell transplantation; Gene therapy; Tissue engineering; Tissue induction

Indexed keywords

SIGNAL PEPTIDE;

ARTICLE; BIOETHICS; BONE REGENERATION; CELL TRANSPLANTATION; DENTISTRY; GENE THERAPY; HUMAN; METHODOLOGY; PHYSIOLOGY; TISSUE ENGINEERING; TISSUE REGENERATION; TOOTH IMPLANTATION;

BIOETHICAL ISSUES; BONE REGENERATION; CELL TRANSPLANTATION; DENTAL IMPLANTS; DENTISTRY; GENE THERAPY; GUIDED TISSUE REGENERATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; TISSUE ENGINEERING;

EID: 67949086740     PISSN: 09709290     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0970-9290.52895     Document Type: Article

References (35)

1. Crag RG, Ward ML, editors. Restorative dental materials. St. Louis: Mosby-Year Book; 1996.
2. Nerem R, Sambanis A. Tissue engineering: From biology to biological substitutes. Tissue Engg 1995;1:3-13.
3. Kim BS, Nikolovski J, Bonadio J, Smiley J, Mooney DJ. Engineered smooth muscle tissues: Regulating cell phenotype with the scaffold. Exp Cell Res 1999;251:318-28.
4. Caudill RF. Guided bone regeneration and implants: History and case reports. In: Block MS, Kent JN, Guerra LR, editors. Implants in dentistry. Philadelphia: Saunders; 1997. p. 183-91.
5. Becker W. Guided tissue regeneration for periodontal defects. In: Polson AM, editor. Periodontal regeneration: Current status and directions. Chicago: Quinte4ssence Publishing; 1994. p. 137-50.
6. Uris Mr. Bone: Formation by auto induction. Science 1965;150:893-9.
7. Cochran DL, Wozney JM. Biological mediators for periodontal regeneration. Periodontal 2000 1999;19:40-58.
8. Polverini PJ. The pathophsiology of angiogenesis. Crit Rev Biol Med 1995;6:230-47.
9. Heiji L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-14.
10. Available from: http//www.forsyth.org. [cited in 2002 Oct]. Journal of Dental Research.
11. Sheridan ME, Shea LD, Peters MC, Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000;64:91-102.
12. Morrison G. Advances in the skin trade. Mech Engg 1999;121:40-3.
13. Garlic JA, Fenjves ES. Keratinocyte gene transfer and gene therapy. Crit Rev Oral Bio Med 1996;7:204-21.
14. Mizuno H, Emi N, Abe A, Takahashi I, Kojima T, Saito H, et al . Successful culture and sustatinability in vivo of genemodified human oral mucosal epithelium. Hum Gene Ther 1999;10:825-30.
15. Puelacher WC, Money D, Palge KT, Upton J, Vacanti JP, Vacanti CA. Design of nasoseptal cartilage replacements synthesized form biodegradable polymers and chondrocytes. Biomaterials 1994;15:774-8.
16. Cao Y, Vacanti JP, Paige KT, Upton J, Vacanti CA. Transplantation of chondrocytes utilizing a polymer-cell construct to product to produce tissue-engineered cartiage in the shape of a human ear. Plast Reconstr Surg 1997;100:297-304.
17. Nor JE, Christensen J, Mooney DJ, Poleverini PJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999;154:375-84.
18. Biosed ® - Oral Bone ® : Feb. 2004.
19. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, et al . T lymphocytes -directed gene therapy for ADA -SCID: Initial trial results after 4 years. Science 1995;270:475-80.
20. Anderson WF. Human gene therapy. Nature 1998;392:25-30.
21. Nabel GJ. Development of optimized vectors for gene theraphy. Proc Nati Acad Sci USA 1999;96:326-6.
22. Testimony on ′gene therapy: Is there oversight for patient safety?′by Amypatterson,M.D. Dircctor,Office of biotechnology activities.National institute of health. U.S. department of health and human services.
23. Mao JJ, Giannobile WV, Helms JA, Hollister SJ, Krebsbach PH, Longaker MT, et al . Craniofacial tissue engineering by stems Cells. J Dent Res 2006;85:966-79.
24. Peter SJ, Miller ST, Zhu G, Yasko AW, Mikos AG. In vivo degradation of a poly(propylenefumarate) / b-tracalcium phosphate injectable composite scaffold. J Biomed Mater Res 1998;41:1-7.
25. Bouhadir KH, Haussman D, Mooney DJ. Synthesis and mechanical properties of crosslinked poly (aldehyde gulurante) hydrogels. Polymer 1999;40:3575-84.
26. Gleich LL, Gluckman JL, Armstrong S, Biddinger PW, Miller MA, Balakrishnan K, et al . Alloantigen gene theraphy for squamous cell carcinoma
27. of the head and neck: Results of a phase -1trial. Arch Otolaryngol Head Neck Surg 1998;124:1097-104.
28. Wollenberg B, Kastenbauer, Mundl H, Schaumberg J, Mayer A, Andratschke M, et al . Gene theraphy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II- IV with a single interumoral injection of hIL - 2 plasmids formulated in DOTMA/ Chol. Hum Gene Ther 1999;10:141-7.
29. Myers JN. The use of biological therapy in cancer of the headand neck. Curr Prob Cancer 1999;23:106-34.
30. Baum BJ, Wang S, Cukierman E, Delporte C, Kagami H, Marmary Y, et al . Re-engineering the functions of a terminally differentiated epitheial cell in vivo . Ann N Y Acad Sci 1999;875:294-300.
31. Delporte C, O′Connell BC, He X, Lancaster HE, O′Connell AC, Agre P, et al . Increased fluid secretion following adenoviral medicated transfer of the aquaporin -1 C DNA to irradiated rat salivary glands. Proc Natl Acad Sci U S A 1997;94:3268-73.
32. Bach FH, Fineberg HV. Call for a moratorium on xenotransplants. Nature 1998;391:326.
33. Hunkeler D. Bioatificial organs risks and requirements. Ann N Y Acad Sci 1999;875:1-6.
34. Weiss RA. Xenografts and retroviruses. Science 1999;285;12s21-2.
35. Stolberg SG. Could this pig save your life? N Y Times Magz 1999; 3:46-51.